|
C7ORF42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.410500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.043800E-03 |
| Normal-vs-Stage2 |
2.915600E-01 |
| Normal-vs-Stage3 |
5.173600E-04 |
| Normal-vs-Stage4 |
1.441500E-04 |
| Stage1-vs-Stage2 |
2.274200E-01 |
| Stage1-vs-Stage3 |
2.871400E-01 |
| Stage1-vs-Stage4 |
9.466200E-02 |
| Stage2-vs-Stage3 |
6.132500E-02 |
| Stage2-vs-Stage4 |
3.831600E-02 |
| Stage3-vs-Stage4 |
5.633200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.432600E-04 |
| Normal-vs-AfricanAmerican |
1.386770E-01 |
| Normal-vs-Asian |
2.600400E-02 |
| Caucasian-vs-AfricanAmerican |
4.215600E-01 |
| Caucasian-vs-Asian |
5.702800E-01 |
| AfricanAmerican-vs-Asian |
7.239200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.238000E-03 |
| Normal-vs-Female |
8.835500E-04 |
| Male-vs-Female |
7.142400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.084800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.380000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.608500E-04 |
| Normal-vs-Age(81-100Yrs) |
7.272200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.353800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.503400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.633800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.607600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.148400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.193600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.231700E-04 |
| Classical-VS-Follicular |
4.407200E-01 |
| Classical-VS-Other |
6.628000E-02 |
| Classical-VS-Normal |
9.915100E-03 |
| Tall-VS-Follicular |
3.102400E-02 |
| Tall-VS-Other |
6.407000E-01 |
| Tall-VS-Normal |
1.70404999999541E-05 |
| Follicular-VS-Other |
2.191400E-01 |
| Follicular-VS-Normal |
1.480290E-02 |
| Other-VS-Normal |
1.014000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.196900E-03 |
| Normal-vs-N1 |
1.55786999999075E-05 |
| N0-vs-N1 |
1.307880E-02 |
|
|
